[1] [4] Treatment usually begins with a 0.25 mg weekly dose for 4 weeks (for tolerability), then increases to 0.5 mg weekly, with a maintenance dose of 0.5-1 mg weekly as determined by your healthcare professional
When to Talk to Your Clinician Report large or spreading bruises, unexpected bleeding, persistent constipation that does not respond to: Basic measures Severe abdominal pain New muscle weakness Also discuss any routine medications that increase bleeding risk so your prescriber can adjust monitoring or dosing
Armstrong MJ, Gaunt P, Aithal GP et al (2016) Liraglutide safety and efficacy in patients with nonalcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
Hereditary MTC The clinical syndromes associated with MTC have been discovered and rediscovered over the past century
Impact of osteoporosis and osteoporosis medications on fracture healing: A narrative review